BeiGene, Ltd. (BGNE)

Basic

  • Market Cap

    $19.06B

  • EV

    $16.64B

  • Shares Out

    104.1M

  • Revenue

    $2,204.47M

  • Employees

    10,000

Margins

  • Gross

    5.73%

  • EBITDA

    -55.11%

  • Operating

    -58.67%

  • Pre-Tax

    -41.1%

  • Net

    -43.52%

  • FCF

    -80.76%

Returns (5Yr Avg)

  • ROA

    -22.86%

  • ROE

    -51.8%

  • ROCE

    -43.8%

  • ROIC

    -178.54%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $285.19

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $21.13

  • Earnings (Dil)

    -$9.28

  • FCF

    -$17.07

  • Book Value

    $36.16

Growth (CAGR)

  • Rev 3Yr

    102.45%

  • Rev 5Yr

    69.47%

  • Rev 10Yr

    —

  • Dil EPS 3Yr

    -22.48%

  • Dil EPS 5Yr

    -0.92%

  • Dil EPS 10Yr

    —

  • Rev Fwd 2Yr

    45.83%

  • EBITDA Fwd 2Yr

    —

  • EPS Fwd 2Yr

    —

  • EPS LT Growth Est

    -38.66%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

198.2

428.2

308.9

1,176.3

1,415.9

2,204.5

Total Revenues % Chg.

-16.8%

116.0%

-27.9%

280.8%

20.4%

76.4%

Cost of Goods Sold, Total

707.7

998.5

1,365.5

1,624.1

1,927.0

2,078.2

Gross Profit

-509.5

-570.3

-1,056.7

-447.9

-511.1

126.2

Selling General & Admin Expenses, Total

195.4

388.2

600.2

991.7

1,278.7

1,417.7

Amortization of Goodwill and Intangible Assets

0.9

1.3

0.8

0.8

0.8

1.9

Other Operating Expenses, Total

196.3

389.6

601.0

992.4

1,279.4

1,419.6

Operating Income

-705.8

-959.9

-1,657.7

-1,440.3

-1,790.5

-1,293.4

Interest Expense, Total

-9.5

-10.3

-18.0

-28.2

-19.1

-8.7

Interest And Investment Income

23.4

19.4

20.0

12.5

71.6

84.6

Net Interest Expenses

13.9

9.1

2.0

-15.8

52.5

76.0

Income (Loss) On Equity Invest.

—

—

-0.5

-1.8

-3.7

-6.4

Other Non Operating Income (Expenses)

2.0

7.2

25.5

9.9

-189.3

-28.2

EBT, Excl. Unusual Items

-689.8

-943.6

-1,630.7

-1,447.9

-1,930.9

-1,252.0

Gain (Loss) On Sale Of Investments

—

—

12.5

9.3

-30.1

-16.9

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

Other Unusual Items

—

—

—

—

—

362.9

EBT, Incl. Unusual Items

-689.8

-943.6

-1,618.2

-1,438.6

-1,961.0

-906.0

Income Tax Expense

-15.8

7.0

10.4

19.2

42.8

53.5

Earnings From Continuing Operations

-674.0

-950.6

-1,628.6

-1,457.8

-2,003.8

-959.5

Minority Interest

0.3

2.0

3.6

—

—

—

Net Income

-673.8

-948.6

-1,625.0

-1,457.8

-2,003.8

-959.5

Net Income to Common Incl Extra Items

-673.8

-948.6

-1,625.0

-1,457.8

-2,003.8

-959.5

Net Income to Common Excl. Extra Items

-673.8

-948.6

-1,625.0

-1,457.8

-2,003.8

-959.5

Total Shares Outstanding

59.7

61.6

91.6

102.7

104.3

104.1

Weighted Avg. Shares Outstanding

55.4

60.1

83.5

92.8

103.1

104.3

Weighted Avg. Shares Outstanding Dil

55.4

60.1

83.5

92.8

103.1

104.3

EPS

-12.2

-15.8

-19.5

-15.7

-19.4

-9.2

EPS Diluted

-12.2

-15.8

-19.5

-15.7

-19.4

-9.3

EBITDA

-695.4

-941.3

-1,625.9

-1,394.8

-1,727.4

-1,214.9